Net Income

NETSOL's major deal with a U.S. auto captive in China highlights the critical role of AI-driven platforms in one of the world's most dynamic markets.

Gartner's first-ever Magic Quadrant for Decision Intelligence Platforms recognizes Sapiens for its forward-thinking, AI-powered enterprise solution.

The European FinTech strengthens its balance sheet with a perpetual bond issuance, signaling strong investor confidence and fueling its expansion plans.

The UK's fitness landscape is being reshaped. New data reveals a surge in niche sports like Pilates and a boom in independent fitness entrepreneurs.

Advocates call for colorectal cancer screening to start at 45 as cases surge in people under 50, raising questions about Canada's readiness.

A new report shows Munich and Hamburg are outpacing rivals in attracting investment, leveraging online credibility as a powerful new tool on the global stage.

At Japan IT Week, ARBOR Technology unveils hardware with NVIDIA Blackwell and AMD EPYC, bringing data center power to the world's harshest environments.

Celebrating 40 years, Hanon Systems pivots beyond cars, targeting the booming data center cooling market with its thermal management expertise.

As a $150M expansion nears completion, Louisiana's largest casino bets on a 20-year veteran to steer its financial future and tribal economic goals.

As automation demand soars, ATS Corp. will meet investors to outline its strategy for navigating market shifts and capitalizing on life sciences growth.

The deepwater oil and gas producer launches a major stock offering to strengthen its balance sheet, causing share dilution but aiming for long-term stability.

With $128.7M in cash and zero debt, Singapore's OMS Energy is leveraging its financial might and a key Saudi Aramco deal to dominate the oilfield market.

After a major strategic pivot, the racing game developer posts a $6.8M net income, proving the success of its focused, simulation-first approach.

Kodiak AI now has 20 driverless trucks on the road, an industry first. But with mounting losses, can its tech innovation outpace its high cash burn?

With a strong cash position and new leadership, Artiva pivots its AlloNK® cell therapy to autoimmune disease, targeting a pivotal trial for RA in 2026.

After a 39% stock crash, Lakeland Industries' former CFO is sued over allegedly misleading investors about the company's deteriorating financial health.

Dallas Nephrology Associates earns its second Burl Osborne Award, a testament to its sustained, innovative commitment to fighting kidney disease in Texas.

With a 7.7% return and 109% funded status, HOOPP secures pensions for 500,000+ healthcare workers while boosting Canada's economy.

Petcurean launches a groundbreaking pet food combining dental and immune support, backed by clinical trials and poised to disrupt the premium market.

The engineering giant saw strong revenue growth in 2025, fueled by its nuclear focus, but one-off costs and investment writedowns hit its bottom line.